143 related articles for article (PubMed ID: 36939390)
1. Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV-Related Oropharyngeal Squamous Cell Carcinoma.
Lee DS; Mahal RS; Tharakan T; Cathryn Collopy ; Kallogjeri D; Thorstad WL; Adkins DR; Oppelt P; Ley J; Wick CC; Zevallos J
Otolaryngol Head Neck Surg; 2023 May; 168(5):1089-1096. PubMed ID: 36939390
[TBL] [Abstract][Full Text] [Related]
2. Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IChoice-01).
Xu T; Shen C; Zhou X; Zhu L; Xiang J; Wang Y; Zhu Y; He X; Ying H; Wang Y; Ji Q; Hu C; Lu X
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):169-178. PubMed ID: 37574169
[TBL] [Abstract][Full Text] [Related]
3. Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Chera BS; Amdur RJ; Tepper JE; Tan X; Weiss J; Grilley-Olson JE; Hayes DN; Zanation A; Hackman TG; Patel S; Sheets N; Weissler MC; Mendenhall WM
Cancer; 2018 Jun; 124(11):2347-2354. PubMed ID: 29579339
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
5. Treatment Modality Impact on Patient-Reported Quality of Life in Human Papilloma Virus-Associated Oropharyngeal Carcinoma.
Plonowska-Hirschfeld KA; Gulati A; Stephens EM; Ochoa E; Xu MJ; Ha PK; Heaton CM; Yom SS; Chan JW; Algazi A; Kang H; Ryan WR
Laryngoscope; 2024 Apr; 134(4):1687-1695. PubMed ID: 37767815
[TBL] [Abstract][Full Text] [Related]
6. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
[TBL] [Abstract][Full Text] [Related]
7. Surgical salvage of human papillomavirus-positive oropharyngeal cancer: Secondary analysis of a randomized controlled trial.
Quan DL; Grauer JS; Sunkara PR; Cramer JD
Cancer; 2023 Feb; 129(3):376-384. PubMed ID: 36401615
[TBL] [Abstract][Full Text] [Related]
8. Surgical margin status and role of adjuvant therapy in human papillomavirus-positive oropharyngeal cancer.
Park YM; Lim JY; Koh YW; Choi EC; Kim SH
Head Neck; 2023 Sep; 45(9):2369-2376. PubMed ID: 37489048
[TBL] [Abstract][Full Text] [Related]
9. Association of Core Biopsy With Extranodal Extension in Surgically Treated Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Zhu VL; Rand DR; Arnold KE; Pagedar NA; Bayon R; Buchakjian MR
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):955-960. PubMed ID: 37433026
[TBL] [Abstract][Full Text] [Related]
10. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
11. A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
Balk M; Rupp R; Sievert M; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Eckstein M; Iro H; Hecht M; Gostian AO
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5489-5497. PubMed ID: 37505261
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
[TBL] [Abstract][Full Text] [Related]
13. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
[TBL] [Abstract][Full Text] [Related]
14. Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.
Takemoto N; Seo Y; Nakahara S; Yoshioka Y; Teshima T; Fujii T; Isohashi F; Otani K; Yoshii T; Takenaka Y; Suzuki M; Fukusumi T; Hanamoto A; Yasui T; Michiba T; Yamamoto Y; Shimamoto S; Tanaka H; Tatsumi M; Ogawa K; Inohara H
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):403-411. PubMed ID: 33373656
[TBL] [Abstract][Full Text] [Related]
15. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
[TBL] [Abstract][Full Text] [Related]
17. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Kwon S; Ahn SH; Jeong WJ; Jung YH; Bae YJ; Paik JH; Chung JH; Kim H
J Transl Med; 2020 Jun; 18(1):240. PubMed ID: 32546279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
